Age-related macular degeneration

N Engl J Med. 2008 Jun 12;358(24):2606-17. doi: 10.1056/NEJMra0801537.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal, Humanized
  • Antioxidants / therapeutic use
  • Bevacizumab
  • Combined Modality Therapy
  • Diet
  • Disease Progression
  • Genetic Therapy
  • Humans
  • Injections, Intralesional
  • Laser Coagulation
  • Macular Degeneration* / diagnosis
  • Macular Degeneration* / pathology
  • Macular Degeneration* / therapy
  • Photochemotherapy
  • Ranibizumab
  • Retina / anatomy & histology
  • Retina / pathology
  • Retina / physiopathology
  • Retinal Drusen
  • Risk Factors
  • Smoking Cessation

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antioxidants
  • Bevacizumab
  • Ranibizumab